Vaccine procurement corruption allegations baseless thesundaily.my - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thesundaily.my Daily Mail and Mail on Sunday newspapers.
FILE PHOTO: Vials of a COVID-19 vaccine candidate, a recombinant adenovirus vaccine named Ad5-nCoV, co-developed by Chinese biopharmaceutical firm CanSino Biologics Inc and a team led by Chinese military infectious disease expert, are pictured in Wuhan, Hubei province, China March 24, 2020. China Daily via REUTERS
KUALA LUMPUR (Bernama): Solution Group Bhd’s (SGB) wholly-owned subsidiary, Solution Biologics Sdn Bhd (SolBio) has signed a finished product and a bulk product agreement today with CanSino Biologics Inc for the supply of the Recombinant Ad5-nCoV vaccine for use against Covid-19.
In a statement, the group said the finished product agreement allows SolBio to purchase and CanSino to supply the finish product vaccine for emergency use in Malaysia.
Solution Group to supply CanSino Covid-19 vaccine in Malaysia | Malaysia malaymail.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from malaymail.com Daily Mail and Mail on Sunday newspapers.
Published on: Thursday, July 29, 2021
By: Bernama
Text Size:
Kuala Lumpur: With Malaysia’s per capita vaccination rate now among the fastest in the world, the National Covid-19 Immunisation Programme (Pick) is seen as an important shield in the fight against the virus and in achieving the herd immunity in the country.
Coordinating Minister for the immunisation programme, Khairy Jamaluddin
(pic), when explaining the programme in the Dewan Rakyat Wednesday, said the percentage of the country’s population having received at least one dose of the Covid-19 had surpassed some developed countries, like Japan, Australia, South Korea and New Zealand.
He said the programme, involving an allocation of RM5.8 billion, initially targeted 80 per cent of the population to receive the vaccine by February next year, but had been brought earlier to December this year after taking into account the current development.
Zimbabwe approves J & J vaccine for emergency use africanews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from africanews.com Daily Mail and Mail on Sunday newspapers.